首页> 美国卫生研究院文献>other >From Bench-Top to Bedside: A Prospective In Vitro Antibiotic Combination Testing (iACT) Service to Guide the Selection of Rationally Optimized Antimicrobial Combinations against Extensively Drug Resistant (XDR) Gram Negative Bacteria (GNB)
【2h】

From Bench-Top to Bedside: A Prospective In Vitro Antibiotic Combination Testing (iACT) Service to Guide the Selection of Rationally Optimized Antimicrobial Combinations against Extensively Drug Resistant (XDR) Gram Negative Bacteria (GNB)

机译:从台式到床头:前瞻性体外抗生素组合测试(iACT)服务指导针对广泛耐药性(XDR)革兰氏阴性菌(GNB)合理选择最佳抗菌组合的选择

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionCombination therapy is increasingly utilized against extensively-drug resistant (XDR) Gram negative bacteria (GNB). However, choosing a combination can be problematic as effective combinations are often strain-specific. An in vitro antibiotic combination testing (iACT) service, aimed to guide the selection of individualized and rationally optimized combination regimens within 48 hours, was developed. We described the role and feasibility of the iACT service in guiding individualized antibiotic combination selection in patients with XDR-GNB infections.
机译:简介联合疗法越来越多地用于抵抗广泛耐药性(XDR)的革兰氏阴性细菌(GNB)。但是,选择一个组合可能会出现问题,因为有效的组合通常是特定于应变的。开发了一种体外抗生素联合检测服务(iACT),旨在指导在48小时内选择个性化和合理优化的联合治疗方案。我们描述了iACT服务在指导XDR-GNB感染患者个体化抗生素组合选择中的作用和可行性。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号